Related Experiment Videos
Introduction to the Theme "New Therapeutic Targets".
Paul A Insel1,2, Susan G Amara3, Terrence F Blaschke4
1Department of Pharmacology, University of California, San Diego, La Jolla, California 92093, USA.
Annual Review of Pharmacology and Toxicology
|January 10, 2019
Summary
This volume of the Annual Review of Pharmacology and Toxicology highlights novel therapeutic targets for numerous diseases. It emphasizes identifying and validating new molecular entities for drug discovery and development.
Area of Science:
- Pharmacology and Toxicology
- Drug Discovery and Development
- Molecular Medicine
Background:
- The Annual Review of Pharmacology and Toxicology, Volume 59, focuses on the critical theme of "New Therapeutic Targets."
- This volume addresses unmet medical needs across a spectrum of conditions requiring novel therapeutic strategies.
- It builds upon previous themes related to drug action, precision medicine, and innovative therapeutic approaches.
Purpose of the Study:
- To review and synthesize current research on novel therapeutic targets for various diseases.
- To highlight the identification, validation, and utility of new molecular entities in drug discovery.
- To provide insights into emerging pharmacological and toxicological advancements.
Main Methods:
- Compilation and review of peer-reviewed articles within the specified volume.
- Focus on research detailing the discovery and validation of new therapeutic targets.
- Analysis of studies exploring novel molecular entities and their therapeutic potential.
Main Results:
- Comprehensive overview of therapeutic targets for conditions including type 2 diabetes, heart failure, obesity, neurodegenerative diseases, cancer, and more.
- Emphasis on the identification and validation of new or unexpected molecular entities as drug targets.
- Discussion of the practical utility of these novel targets in therapeutic development.
Conclusions:
- The identified novel therapeutic targets represent significant advancements in addressing diverse diseases.
- The focus on new molecular entities offers promising avenues for future drug discovery and development.
- This volume serves as a crucial resource for researchers and clinicians in pharmacology and toxicology.